The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

5-HIAA     2-(5-hydroxy-1H-indol-3- yl)ethanoic acid

Synonyms: Lopac-H-8876, CHEMBL395915, SureCN138121, ACMC-1BTZR, CCRIS 4423, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hydroxyindoleacetic acid


Psychiatry related information on Hydroxyindoleacetic acid


High impact information on Hydroxyindoleacetic acid


Chemical compound and disease context of Hydroxyindoleacetic acid


Biological context of Hydroxyindoleacetic acid


Anatomical context of Hydroxyindoleacetic acid


Associations of Hydroxyindoleacetic acid with other chemical compounds


Gene context of Hydroxyindoleacetic acid


Analytical, diagnostic and therapeutic context of Hydroxyindoleacetic acid


  1. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. von der Ohe, M.R., Camilleri, M., Kvols, L.K., Thomforde, G.M. N. Engl. J. Med. (1993) [Pubmed]
  2. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. Van Woert, M.H., Rosenbaum, D., Howieson, J., Bowers, M.B. N. Engl. J. Med. (1977) [Pubmed]
  3. Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. Calapai, G., Corica, F., Corsonello, A., Sautebin, L., Di Rosa, M., Campo, G.M., Buemi, M., Mauro, V.N., Caputi, A.P. J. Clin. Invest. (1999) [Pubmed]
  4. Serotonin and 5-hydroxyindoleacetic acid are increased in the sigmoid colon in severe idiopathic constipation. Lincoln, J., Crowe, R., Kamm, M.A., Burnstock, G., Lennard-Jones, J.E. Gastroenterology (1990) [Pubmed]
  5. Abnormalities in CNS monoamine metabolism in anorexia nervosa. Kaye, W.H., Ebert, M.H., Raleigh, M., Lake, R. Arch. Gen. Psychiatry (1984) [Pubmed]
  6. Effect of low-dose clorgyline on 24-hour urinary monoamine excretion in patients with rapidly cycling bipolar affective disorder. Linnoila, M., Karoum, F., Potter, W.Z. Arch. Gen. Psychiatry (1982) [Pubmed]
  7. Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Higley, J.D., Mehlman, P.T., Higley, S.B., Fernald, B., Vickers, J., Lindell, S.G., Taub, D.M., Suomi, S.J., Linnoila, M. Arch. Gen. Psychiatry (1996) [Pubmed]
  8. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Coccaro, E.F., Kavoussi, R.J., Hauger, R.L., Cooper, T.B., Ferris, C.F. Arch. Gen. Psychiatry (1998) [Pubmed]
  9. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Kruesi, M.J., Rapoport, J.L., Hamburger, S., Hibbs, E., Potter, W.Z., Lenane, M., Brown, G.L. Arch. Gen. Psychiatry (1990) [Pubmed]
  10. Effects of sleep deprivation on mood and central amine metabolism in depressed patients. Post, R.M., Kotin, J., Goodwin, F.K. Arch. Gen. Psychiatry (1976) [Pubmed]
  11. Ethanol inhibition of transport of 5-hydroxyindoleacetic acid from cerebrospinal fluid. Tabakoff, B., Bulat, M., Anderson, R.A. Nature (1975) [Pubmed]
  12. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. Eddahibi, S., Hanoun, N., Lanfumey, L., Lesch, K.P., Raffestin, B., Hamon, M., Adnot, S. J. Clin. Invest. (2000) [Pubmed]
  13. Novel flushing provoked by volatile anesthetics in Mastomys natalensis bearing a transplantable substrain of gastric carcinoid that predominantly secretes serotonin. Hosoda, S., Suyama, M., Saito, T., Kohmura, Y., Hosoda, R. J. Natl. Cancer Inst. (1984) [Pubmed]
  14. Transplantable argyrophilic gastric carcinoid of Mastomys natalensis secreting both histamine and serotonin. Hosoda, S., Suzuki, K., Sudo, K., Yoshida, N., Tanaka, C. J. Natl. Cancer Inst. (1979) [Pubmed]
  15. Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Swedo, S.E., Leonard, H.L., Kruesi, M.J., Rettew, D.C., Listwak, S.J., Berrettini, W., Stipetic, M., Hamburger, S., Gold, P.W., Potter, W.Z. Arch. Gen. Psychiatry (1992) [Pubmed]
  16. Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Botez, M.I., Young, S.N., Bachevalier, J., Gauthier, S. Ann. Neurol. (1982) [Pubmed]
  17. Cerebral glucose metabolism, CSF 5-HIAA levels, and aggressive behavior in rhesus monkeys. Doudet, D., Hommer, D., Higley, J.D., Andreason, P.J., Moneman, R., Suomi, S.J., Linnoila, M. The American journal of psychiatry. (1995) [Pubmed]
  18. Hypertrophic gastritis associated with increased gastric mucosal prostaglandin E2 concentrations in a patient with the carcinoid syndrome. Boyd, E.J., Hulks, G., Thomas, J.S., McColl, K.E. Gut (1988) [Pubmed]
  19. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT. Abrams, R., Essman, W.B., Taylor, M.A., Fink, M. Biol. Psychiatry (1976) [Pubmed]
  20. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Nielsen, D.A., Goldman, D., Virkkunen, M., Tokola, R., Rawlings, R., Linnoila, M. Arch. Gen. Psychiatry (1994) [Pubmed]
  21. High-dose selegiline in treatment-resistant older depressive patients. Sunderland, T., Cohen, R.M., Molchan, S., Lawlor, B.A., Mellow, A.M., Newhouse, P.A., Tariot, P.N., Mueller, E.A., Murphy, D.L. Arch. Gen. Psychiatry (1994) [Pubmed]
  22. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Zhou, Z., Roy, A., Lipsky, R., Kuchipudi, K., Zhu, G., Taubman, J., Enoch, M.A., Virkkunen, M., Goldman, D. Arch. Gen. Psychiatry (2005) [Pubmed]
  23. Self-mutilation in personality disorders: psychological and biological correlates. Simeon, D., Stanley, B., Frances, A., Mann, J.J., Winchel, R., Stanley, M. The American journal of psychiatry. (1992) [Pubmed]
  24. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Laine, K., Heikkinen, T., Ekblad, U., Kero, P. Arch. Gen. Psychiatry (2003) [Pubmed]
  25. Serotonin and 5-hydroxyindoleacetic acid in brains of suicide victims. Comparison in chronic schizophrenic patients with suicide as cause of death. Korpi, E.R., Kleinman, J.E., Goodman, S.I., Phillips, I., DeLisi, L.E., Linnoila, M., Wyatt, R.J. Arch. Gen. Psychiatry (1986) [Pubmed]
  26. Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys. Higley, J.D., Mehlman, P.T., Taub, D.M., Higley, S.B., Suomi, S.J., Vickers, J.H., Linnoila, M. Arch. Gen. Psychiatry (1992) [Pubmed]
  27. Circumvention of defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester. Jonas, A.J., Butler, I.J. J. Clin. Invest. (1989) [Pubmed]
  28. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Pickar, D., Owen, R.R., Litman, R.E., Konicki, E., Gutierrez, R., Rapaport, M.H. Arch. Gen. Psychiatry (1992) [Pubmed]
  29. Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. Limson, R., Goldman, D., Roy, A., Lamparski, D., Ravitz, B., Adinoff, B., Linnoila, M. Arch. Gen. Psychiatry (1991) [Pubmed]
  30. Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Virkkunen, M., De Jong, J., Bartko, J., Linnoila, M. Arch. Gen. Psychiatry (1989) [Pubmed]
  31. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. Mamounas, L.A., Blue, M.E., Siuciak, J.A., Altar, C.A. J. Neurosci. (1995) [Pubmed]
  32. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Jönsson, E., Sedvall, G., Brené, S., Gustavsson, J.P., Geijer, T., Terenius, L., Crocq, M.A., Lannfelt, L., Tylec, A., Sokoloff, P., Schwartz, J.C., Wiesel, F.A. Biol. Psychiatry (1996) [Pubmed]
  33. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. Altar, C.A., Boylan, C.B., Fritsche, M., Jones, B.E., Jackson, C., Wiegand, S.J., Lindsay, R.M., Hyman, C. J. Neurochem. (1994) [Pubmed]
  34. Alterations of [3H]8-OH-DPAT and [3H]ketanserin binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Rao, V.L., Butterworth, R.F. Neurosci. Lett. (1994) [Pubmed]
  35. Effects of thyrotropin-releasing hormone on prolactin, growth hormone and corticosterone secretions in adult male rats treated with pentobarbital or morphine. Collu, R., Clermont, M.J., Ducharme, J.R. Eur. J. Pharmacol. (1976) [Pubmed]
  36. Cerebrospinal fluid monoamine metabolite levels in male arsonists. Virkkunen, M., Nuutila, A., Goodwin, F.K., Linnoila, M. Arch. Gen. Psychiatry (1987) [Pubmed]
  37. Monoamine metabolites in CSF and suicidal behavior. Träskman, L., Asberg, M., Bertilsson, L., Sjöstrand, L. Arch. Gen. Psychiatry (1981) [Pubmed]
  38. Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease. Denney, W.D., Kemp, W.E., Anthony, L.B., Oates, J.A., Byrd, B.F. J. Am. Coll. Cardiol. (1998) [Pubmed]
  39. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid. Geracioti, T.D., Keck, P.E., Ekhator, N.N., West, S.A., Baker, D.G., Hill, K.K., Bruce, A.B., Wortman, M.D. Biol. Psychiatry (1998) [Pubmed]
  40. 5,6-Dimethylxanthenone-4-acetic acid in the treatment of refractory tumors: a phase I safety study of a vascular disrupting agent. McKeage, M.J., Fong, P., Jeffery, M., Baguley, B.C., Kestell, P., Ravic, M., Jameson, M.B. Clin. Cancer Res. (2006) [Pubmed]
WikiGenes - Universities